2026 AACR Taiwan Night On-site Report: Innovative R&D in DDR and ADC Gains International Attention / "New Approach Methods (NAMs)" Aligned with FDA Modernization Act 3.0, a New Trend in Drug Discovery Validation
NQ Score
42/100
N1 Content Completeness
4
AI Summary (NQ-processed)
At the 2026 AACR Annual Meeting, CancerFree Biotech hosted "AACR Taiwan Night," where innovative R&D in DDR and ADC garnered international attention. Experts from Taiwan, Japan, and the US discussed global strategies for ADC and immunotherapy, highlighting the growth of Taiwan's biotechnology and deepening international collaboration.